ArticleBioresources and bioprocessing2025
Phytoextract-mediated Cupper nanoparticles via Acacia saligna: synthesis, characterization and in vitro anticancer and apoptosis inducing effects.
Article in Bioresources and bioprocessing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Copper oxide nanoparticles (CuO NPs) have been utilized in various applications over the past few decades. This investigates the anti-cancer and apoptosis-inducing effects of green synthesis of copper oxide nanoparticles mediated by using Acacia saligna flower extract. The flower extract was mixed with a solution of copper sulphate pentahydrate (CuSO4·5H2O) and sodium hydroxide (NaOH) as a catalyst. UV-Vis spectroscopy, FTIR (Fourier Transform Infrared Spectroscopy), XRD (X-ray Diffraction), and SEM (Scanning electron microscope), EDS (Energy Dispersive Spectroscopy) and TEM (Transmission Electron Microscopy) analysis were conducted to characterize the synthesized CuO NPs. The average particle size of the NPs was found to be 8.488 nm. Additionally, the CuO NPs exhibited noteworthy anticancer activity against the MCF-7, PC3, HT-29, and U-87MG cell lines (18.11 ± 25, 8.92 ± 0.73, 19.48 ± 0.24, and 26.08 ± 0.57, respectively). In particular, the CuO NPs demonstrated a significant effect on the human colorectal adenocarcinoma cell line (HT-29) with an IC50 value of 19.48 ± 0.24 µg/mL, surpassing that of the standard (Cis-platin, 22.20 ± 0.72). The CuO NPs also induced apoptotic-mediated programmed cell death in cancer cell lines. In conclude, this investigation suggests that green-synthesized CuO NPs with Acacia saligna flower extract could serve as a viable alternative for anticancer applications in biomedicine. However, further research is needed to understand the detailed mechanisms of action and evaluate their in vivo efficacy to better establish their potential for clinical applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.